Trademark: 79080850
Word
INFLAMMATION AT INTERFACES
Status Date
Monday, October 25, 2021
Registration Number
3972615
Registration Date
Tuesday, June 7, 2011
Filing Date
Monday, February 22, 2010
Published for Opposition
Tuesday, March 22, 2011
41 Education and training, in particular arranging and conducting of seminars and workshops and academic enrichment programs in the field of inflammation medicine for young academics
35 [ Business management and administration, operation of business for others, namely, medical care and research organizations, in particular in the field of inflammation medicine; organization and arrangement of trade exhibitions and trade fairs for scientific businesses, commercial and advertising purposes; business marketing services and public relations; distribution of advertising material; procurement of service contracts for others, namely, procuring of labor contracting services for others ]
44 [ Medical services, in particular medical and clinical analysis in the nature of medical analysis of inflammation medicine and inflammation related conditions; therapeutic and medical treatment and attendance, namely, providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns, and including analysis of patient's environment, analysis of life circumstances, genetically disposition analysis, and hereditary family analysis; services of a hospital; medical care, namely, medical care for inflammation related conditions ]
42 Scientific services and research activities, in particular scientific research for medical purposes, namely providing medical research, clinical research and interdisciplinary medical research in the field of inflammation medicine, including fundamental research, contract research and clinical trials; pharmaceutical drug development services and conducting clinical trials featuring the application of new therapies and therapy approaches and diagnostic methods for scientific purposes; scientific study and research in the field of inflammation medicine featuring reports and surveys; industrial analysis, namely, conducting technical project studies in the field of high-throughput of molecular diagnostics, and translational and clinical research based on molecular makeup of patients
The mark consists of three crescent-shaped curved lines, with the top crescent in blue, the bottom right crescent in red and the bottom left crescent in gray. Beneath the three crescents is the wording "Inflammation at Interfaces" in gray
The color(s) red, grey and blue is/are claimed as a feature of the mark.
"INFLAMMATION"
Sep 25, 2022
Partial Invalidation Processed By The Ib
Aug 23, 2022
Generic Madrid Transaction Sent To Ib
Aug 23, 2022
Generic Madrid Transaction Created
Jun 25, 2022
Partial Invalidation Of Reg Ext Protection Created
Oct 25, 2021
Notice Of Acceptance Of Sec. 71 - E-Mailed
Oct 25, 2021
Registered - Partial Sec 71 Accepted
Oct 25, 2021
Case Assigned To Post Registration Paralegal
May 20, 2021
Teas Section 71 Received
Dec 4, 2020
New Representative At Ib Received
Jun 7, 2020
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
Apr 16, 2020
International Registration Renewed
Dec 1, 2018
Invalidation Reviewed - No Action Required By Office
Nov 16, 2018
Partial Invalidation Of Reg Ext Protection Created
May 4, 2018
Partial Invalidation Processed By The Ib
Mar 15, 2018
Generic Madrid Transaction Sent To Ib
Mar 15, 2018
Generic Madrid Transaction Created
Mar 5, 2018
Partial Invalidation Of Reg Ext Protection Created
Jul 5, 2017
Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed
Jul 5, 2017
Registered - Partial Sec. 71 Accepted & Sec. 15 Ack.
Jul 3, 2017
Case Assigned To Post Registration Paralegal
Jun 6, 2017
Teas Section 71 & 15 Received
Feb 25, 2013
Final Decision Transaction Processed By Ib
Oct 27, 2011
Final Disposition Notice Sent To Ib
Oct 27, 2011
Final Disposition Processed
Sep 7, 2011
Final Disposition Notice Created, To Be Sent To Ib
Jun 7, 2011
Registered-Principal Register
Mar 22, 2011
Published For Opposition
Mar 3, 2011
Notification Of Possible Opposition Sent To Ib
Mar 3, 2011
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 2, 2011
Notice Of Publication
Feb 16, 2011
Law Office Publication Review Completed
Feb 11, 2011
Assigned To Lie
Jan 19, 2011
Approved For Pub - Principal Register
Jan 19, 2011
Teas/Email Correspondence Entered
Jan 19, 2011
Correspondence Received In Law Office
Jan 19, 2011
Teas Request For Reconsideration Received
Dec 3, 2010
Final Refusal Mailed
Dec 2, 2010
Final Refusal Written
Nov 29, 2010
Teas/Email Correspondence Entered
Nov 29, 2010
Correspondence Received In Law Office
Nov 29, 2010
Teas Response To Office Action Received
Jul 2, 2010
Refusal Processed By Ib
Jun 3, 2010
Non-Final Action Mailed - Refusal Sent To Ib
Jun 3, 2010
Refusal Processed By Mpu
Jun 3, 2010
Non-Final Action (Ib Refusal) Prepared For Review
Jun 2, 2010
Non-Final Action Written
May 26, 2010
Assigned To Examiner
Apr 20, 2010
Application Filing Receipt Mailed
Apr 16, 2010
New Application Office Supplied Data Entered In Tram
Apr 15, 2010
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
